Drugs / GCPGC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00969826 | Sep 2008 → Jan 2009 | — | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCPGC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00969826 ↗ |
| Route | Subcutaneous | “A single subcutaneous administration of GCPGC 30 μg/kg, GCPGC 100 μg/kg, GCPGC 300 μg/kg, placebo or Neulasta 100 μg/kg” NCT00969826 ↗ |